Terveystalo to host Q3/2026 results webcast and provide an update on the progress of its ARC strategy on 21 October 2026
Terveystalo to host Q3/2026 results webcast and provide an update on the progress of its ARC strategy on 21 October 2026
Terveystalo Press Release, 7 October 2026 at 13:30 EEST
Terveystalo Plc will publish its Interim Report for January-September 2026 on Wednesday, 21 October 2026 at approximately 9:00 a.m. EEST. The report and presentation materials will be available after publication on Terveystalo’s Investor Relations website.
Terveystalo will host an English-language results webcast and conference call on the same day at 10:30 a.m. EEST. The webcast can be followed at: https://terveystalo.events.inderes.com/q3-2026
Conference call: https://events.inderes.com/terveystalo/q3-2026/dial-in
To participate in the conference call, please register via the link above. After registration, you will receive a phone number and conference ID to access the call.
Progress of the ARC strategy and Oral Health
As part of the Q3/2026 results webcast, Terveystalo will provide a brief update on the execution of the ARC strategy. In addition, Ville Pesonen, SVP, Oral Health, will introduce himself to investors and provide an overview of the Oral Health business following the completion of the Hohde Group acquisition in September 2026.
Capital Markets Day rescheduled
Terveystalo has decided to postpone its previously planned Capital Markets Day from December 2026 to spring 2027.
The purpose of the postponement is to ensure that the company can provide a comprehensive update on the execution of its ARC strategy, the development of its key growth platforms and the impact of its strategic transactions. The Silmäasema transaction is a key element of the ARC strategy, and Terveystalo believes that hosting the Capital Markets Day after completion of the transaction will enable the company to provide investors with a clearer view of strategy execution, the development of its growth platforms and the long-term value creation potential of the combined business. Terveystalo will announce the exact date of the Capital Markets Day at a later stage.
For further information:
Liisa-Maija Seppänen, Senior Investor Relations Manager
liisa-maija.seppanen@terveystalo.com
Terveystalo in brief
Terveystalo is the largest private healthcare service provider in Finland in terms of revenue and one of the leading occupational health providers in both Finland and Sweden.
We aim to create seamless, compassionate, and effective healthcare of the future. We offer comprehensive primary care, specialised care, and well-being services for corporate clients, insurance companies, consumers and public-sector customers. Terveystalo's digital appointments are available anytime, anywhere, 24/7. The Terveystalo app has around 2.7 million registered users. We provide services through our extensive network of clinics and hospitals across Finland. In Sweden, we offer preventive occupational health services through our subsidiary, Feelgood.
In 2025, Terveystalo served approximately 1.2 million individual customers, and there were around 7.2 million customer visits in Finland. Terveystalo employs around 14,400 professionals in healthcare and other fields.
Terveystalo is listed on Nasdaq Helsinki and has a strong Finnish ownership base. www.terveystalo.com